HUM Quantitative Stock Analysis

Validea's analysis of Humana (HUM) using Pim van Vliet's Multi-Factor Investor model, which targets low volatility, strong momentum, and high net payout yields, resulted in an 87% rating. This indicates "some interest" in the large-cap healthcare stock based on its underlying fundamentals and valuation, despite the model noting neutral performance in momentum and net payout yield, and a "FAIL" for its final rank. The model's premise suggests low-volatility stocks can outperform with less risk.

Analysis

Humana Inc. (HUM) presents a mixed profile according to Validea's quantitative screen based on Pim van Vliet's multi-factor strategy. The model, which favors low-volatility stocks with strong momentum and high net payout yields, assigned HUM a score of 87%, indicating a moderate level of interest. This positive score is primarily driven by the stock meeting the model's criteria for market capitalization and low standard deviation, aligning with the low-volatility component of the strategy. However, the analysis reveals significant caveats: HUM received a 'NEUTRAL' rating for its 'Twelve Minus One Momentum' and 'Net Payout Yield' factors. Most critically, despite the 87% score, the stock's 'Final Rank' registers as a 'FAIL' in the model's summary table, creating a direct contradiction that suggests the underlying components do not collectively meet the strategy's threshold for a strong recommendation.

Key Decisions for Investors

• Investors should view this report as a preliminary screen rather than a conclusive buy signal, focusing on the discrepancy between the high 87% rating and the 'FAIL' in its final rank.
• For those employing low-volatility strategies, HUM's passing grade on standard deviation is a positive data point, but the neutral momentum and payout yield ratings warrant further investigation into the company's recent performance and capital return policies.
• Given the model's mixed results, it is prudent to scrutinize HUM's fundamental growth drivers and competitive positioning within the healthcare sector before committing capital based on this specific factor analysis.